Equitec Proprietary Markets »

Inhibrx Biosciences shares owned by Equitec Proprietary Markets

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Equitec Proprietary Markets from 13F filings

Historical chart of Equitec Proprietary Markets investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Equitec Proprietary Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Equitec Proprietary Markets

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 96k 15.66
2024-06-30 $1.3M 93k 14.17

More positions owned by Equitec Proprietary Markets

United States Steel Corporation (X)
Paramount Global Class B Com (PARA)
Capri Holdings SHS (CPRI)
Kellogg Company Call Option (K)
Siriusxm Holdings Common Stock (SIRI)
Poseida Therapeutics I Call Option (PSTX)
Amedisys (AMED)
Spirit Aerosystems Hldgs Com Cl A (SPR)
Cadiz Com New (CDZI)
Gamestop Corp Cl A Call Option (GME)
Babcock & Wilcox Enterpr (BW)
Wk Kellogg Com Shs (KLG)
Discover Financial Services (DFS)
Bigbear Ai Hldgs *w Exp 12/08/202 (BBAI.WS)
Pharmacyte Biotech Com New (PMCB)

View all positions for Equitec Proprietary Markets

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Walleye Trading Advisors
Sofinnova Ventures
Vanguard Group
Slotnik Capital
Millennium Management
Geode Capital Management
Caption Management
Kennedy Capital Management
State Street Corporation
Arrowpoint Asset Management
Susquehanna International
Schonfeld Strategic Advisors

View all funds holding Inhibrx Biosciences